Close mobile menu×
Close mobile menu

Jai Radhakrishnan, MD

Board Certifications: 
Nephrology, Internal Medicine
Expertise in: 
Amyloidosis
Not Accepting New Patients
Profile Headshot

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Nephrology
  • Internal Medicine

Clinical Expertise

  • Amyloidosis
  • Biopsies
  • Lupus
  • Dialysis
  • Kidney Stones
  • Hypertension
  • Renal Failure
  • Kidney Disease
  • Chronic Glomerular Diseases
  • Nephrotic Syndrome

Education & Training

  • Jawaharlal Institute - India
  • Internship: Lincoln Medical & Mental Health Center
  • Residency: Lincoln Medical & Mental Health Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: Massachusetts General Hospital

Honors & Awards

Teaching Awards
  • 1989: Excellence in Teaching - Golden Apple Award, New York Medical College
  • 1992: Fellow of the Year - Columbia-Presbyterian Medical Center
  • 1994: Junior Attending of the Year, Dept of Medicine
  • 2001: Best Morning Report Attending, Dept of Medicine.
  • 2003: Senior Attending of the Year, Dept of Medicine
  • 2005: Ewig Clinical Education Award, Dept of Medicine.
  • 2006: Daniel V. Kimberg Memorial Teaching Award, Dept of Medicine
  • 2009: Charles W. Bohmfalk Award for Excellence in Pre-clinical Teaching, Columbia University
  • 2010: Member, Glenda Garvey Teaching Academy, Columbia University
  • 2010: Outstanding Teacher of the Year, Columbia University, College of Physicians & Surgeons (Preclinical)
Elite Fellowship Programs
  • Fellow, American Society of Nephrology
  • Fellow, American College of Cardiology
  • Member, Royal College of Physicans (UK)
Professional Recognition
  • 2007: Whos Who among Americas Teachers & Educators
  • 2008, 2009, 2010, 2011: New York Times Magazine Super Doctors
  • 2005, 2008, 2010, 2011: Best Doctors in America
  • 2008: Who's Who Among Executives and Professionals, Honors Edition
  • 2008: Madisons Whos Who
  • 2009: Patients Choice Award

About Jai Radhakrishnan

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease (including glomerular diseases and lupus kidney disease) and intensive care nephrology.

He is a fellow of the American Society of Nephrology and National Kidney Foundation. His commitment to medical education and patient care is exemplified by his numerous teaching awards and his inclusion in the Who's Who among America's Teachers & Educators, America's Best Doctors and Castle Connolly's Top Doctor.

Academic Titles

  • Professor of Medicine at CUMC

Administrative Positions

  • Clinical Chief, Nephrology Division

Committee/Societies/Council Memberships


Elite Fellowships:
 Fellow of the American Society of Nephrology
 Fellow of the National Kidney Foundation

Society Membership
 International Society of Nephrology
 New York Society of Nephrology

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Hindi

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Indemnity
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Indemnity
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
622 West 168th Street
Room PH 4-476
New York, New York 10032
Fax:
(212) 305-4981
Primary

Research

Glomerular disease esp. lupus nephritis. Chronic kidney disease.

Research Interests

  • Epidemiology and treatment protocols for primary glomerular disease
  • Lupus Nephritis

Grants

A MULTI- CENTER, RANDOMIZED, SHAM CONTROLLED, DOUBLE-BLIND, ASCENDING-DOSE STUDY OF EXTRACORPOREAL MESENCHYMAL STROMAL CELL THERAPY (SBI-101 THERAPY) IN SUBJECTS WITH ACUTE KIDNEY INJURY RECEIVING CONTINUOUS RENAL PLACEMENT THERAPY (P&S Industry Clinical Trial)

May 24 2017 - May 24 2022

A PHASE 3B, MULTI-CENTER, OPEN-LABEL TRIAL TO EVALUATE THE LONG TERM SAFETY OF TITRATED IMMEDIATE-RELEASE TOLVAPTAN (OPC 41061, 30 MG TO 120 MG/DAY, SPLIT DOSE) IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (P&S Industry Clinical Trial)

Feb 25 2015 - Feb 25 2020

ADVANCING CLINICAL RESEARCH IN PRIMARY GLOMERULAR DISEASES (UM1) (Federal Gov)

Sep 16 2013 - May 31 2018

A PHASE 2, MULTICENTER, DOUBLE-BLIND, PARALLEL DOSING, RANDOMIZED STUDY OF FRESOLIMUMAB OR PLACEBO IN PATIENTS WITH STEROID-RESISTANT PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (P&S Industry Clinical Trial)

May 21 2013 - May 21 2018

A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL OF RITUXIMAB VERSUS CYCLOSPORINE IN THE TREATMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY (IMN) - MENTOR (P&S Industry Clinical Trial)

Jan 3 2013 - Jan 3 2018

AC 6071103 (P&S Industry Clinical Trial)

Mar 12 2012 - Mar 12 2017

ISN SISTER RENAL CENTER PROGRAM (Private)

Jan 1 2013 - Dec 31 2016

TOLVAPTAN (P&S Industry Clinical Trial)

May 12 2011 - May 12 2016

OTSUKA--156-04-251 (P&S Industry Clinical Trial)

Nov 6 2007 - May 30 2012

EUVOLEMIC AND HYPERVOLEMIC HYPONATREMIA REGISTRY (Private)

May 2 2011 - May 1 2012

Selected Publications

  • Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB. (2010) Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. . Kidney Int. 77(2):152-160
  • Mohan S, Radhakrishnan J (2011) Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy. Clin Nephrol 75(3):233-41
  • Boyden LM, Choi M, Choate KA, et al (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482(7383):98-102
  • Labban B, Arora N, Restaino R, Markowitz G, Valeri A , Radhakrishnan J (2010) The Role of Kidney Biopsy in Heart Transplant Candidates With Kidney Disease Transplantation 89(7):887-893
  • Radhakrishnan J, Uppot RN, Colvin RB (2010) Case records of the Massachusetts General Hospital. Case 5-2010. A 51-year-old man with HIV infection, proteinuria, and edema N Engl J Med ;362(7):636-46
  • Appel GB, Radhakrishnan J, D'Agati V (2008) Secondary Glomerular Disease BRENNER & RECTOR 8 Ed:1067-1126
  • Bhat P, Radhakrishnan J (2008) B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies. Kidney Int 73(3):261-268
  • Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB. (2012) Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis. Clin J Am Soc Nephrol epub: